Navigation Links
DrugRisk Pradaxa Update: Litigation Grows As New Study Adds to Risks
Date:2/19/2013

Denver, CO (PRWEB) February 19, 2013

The medication resource center DrugRisk.com is alerting patients taking the blood thinner Pradaxa for atrial fibrillation that new information for the drug has been added to the site. Amid a new study warning of Pradaxa bleeding risks, reports show the number of patients filing legal claims for injury has increased.

“DrugRisk seeks to improve the safety of patients using popular drugs and medical devices by providing the latest warnings, recalls, studies and litigation news. With a drug like Pradaxa, this information can change monthly,“ explains DrugRisk representative Ryan Mayer.

The resource center contains information that shows experts still disagree about the safety of Pradaxa. The FDA recently issued an update that the drug carries the same risks as warfarin.* However, the American College of Cardiology has warned that Pradaxa use can significantly increase the risk of bleeding complications compared to warfarin.**

Now, DrugRisk has added new information from the Institute for Safe Medication Practices, which ranks anticoagulants like Pradaxa among the most dangerous of outpatient drugs. Also, in reviewing reports of bleeding submitted to the FDA, the Institute found that bleeding caused by Pradaxa is nearly 5 times as likely to result in death than with warfarin.***

In legal news, the resource center has learned that, due to the number of patients filing Pradaxa lawsuits for bleeding side effects, the cases are being sent to a special federal court in Illinois, formally known as MDL No. 2385, IN RE: Pradaxa Product Liability Litigation, Southern District of Illinois.

In the latest update from the Judicial Panel on Multi-District Litigation, court officials indicated the number of Pradaxa lawsuits filed had grown by nearly 17% in recent months and now approaches 200.****

Anyone affected by Pradaxa internal bleeding is urged to speak with a lawyer about their legal options as soon as possible. Due to the specialized nature of federal drug injury cases, the Drug Risk Resource Center only recommends lawyers who are already handling Pradaxa lawsuits.

For more information on the research, side effects and litigation news related to Pradaxa and other drugs, or to speak with a lawyer, visit http://www.DrugRisk.com.

*fda.gov/Drugs/DrugSafety/ucm326580.htm
** http://content.onlinejacc.org/article.aspx?articleid=1206384
***Instutute for Safe Medication Practices, 1/9/13; ismp.org/quarterwatch/pdfs/2012Q2.pdf
****jpml.uscourts.gov/sites/jpml/files/Pending_MDL_Dockets-By-District-January-2013.pdf

Read the full story at http://www.prweb.com/releases/pradaxa-internal-bleeding/side-effects/prweb10442853.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. DrugRisk Pradaxa Lawsuit Update: Court Denys Boehringer’s Protective Order Request
2. DrugRisk Update: Court Allows Charges of Prior Fraud Into Pradaxa Lawsuit
3. DrugRisk Update: NuvaRing Lawsuit Trials to Begin This Year
4. DrugRisk Announces New Pradaxa Health Warning From Australia
5. DrugRisk Adds Latest Health Warnings and Lawsuit Updates for Yaz
6. DrugRisk Announces Updated Information on Mirena Lawsuits
7. DrugRisk Announces Alternative to Mirena IUD May Be Available Soon
8. DrugRisk Center Announces Court Postponement of NuvaRing Lawsuits
9. Pradaxa Lawsuits: Bernstein Liebhard LLP Notes Upcoming Status Conference in Federal Pradaxa Litigation
10. Bernstein Liebhard LLP Launches Pradaxa Lawsuit Website Providing Information on Mounting Pradaxa Litigation, Side Effects
11. Pradaxa Side Effect Problems Continue, as New Report Finds Pradaxa Bleeding More Likely to Result in Death, Bernstein Liebhard LLP Reports
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... June 25, 2016 , ... "With 30 hand-drawn hand gesture animations, FCPX ... Austin - CEO of Pixel Film Studios. , ProHand Cartoon’s package transforms over ... Cut Pro X . Simply select a ProHand generator and drag it above media ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson ... Recently, he has implemented orthobiologic procedures as a method for treating his patients. ... the first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published ... unfamiliar with. The article goes on to state that individuals are now more comfortable ... less common operations such as calf and cheek reduction. The Los Angeles area medical ...
(Date:6/24/2016)... ... ... a crisis. Her son James, eight, was out of control. Prone to extreme mood shifts ... upset him, he couldn’t control his emotions,” remembers Marcy. “If there was a knife ... and say he was going to kill them. If we were driving on the ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... for accelerated orthodontic treatment. Dr. Cheng has extensive experience with all areas of ... AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is a revolutionary adjunct to ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... N.C. , June 24, 2016  Consumers ... decisions and regulators/payers have placed more emphasis on ... environment, patient support programs in the pharmaceutical industry ... patients, medications. Consequently, pharmaceutical companies are focusing on ... they are providing products and services that improve ...
(Date:6/24/2016)... -- Dublin ... the " Global Markets for Spectroscopy Equipment" ... This report focuses on the global market ... its applications in various applications. The report deals with ... main industries: pharmaceutical and biotechnology, food and beverage, and ...
(Date:6/24/2016)... and SAN CLEMENTE, Calif. , June ... -based mobile pulmonary function testing company, is now able to ... devices developed by ndd Medical Technologies , Inc. ... done in hospital-based labs.  Thanks to ndd,s EasyOne PRO ® , ... , can get any needed testing done in the comfort of ...
Breaking Medicine Technology: